Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
30 results about "Aceclidine" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Aceclidine (Glaucostat, Glaunorm, Glaudin) is a parasympathomimetic miotic agent used in the treatment of narrow angle glaucoma. It decreases intraocular pressure.
Compositions and Methods for the Treatment of Presbyopia
ActiveUS20150065511A1Eliminating optical aberrationImprove visual acuityBiocideSenses disorderAdrenergicMedicine
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably use aceclidine separate or together with a cycloplegic agent and / or with a nonionic surfactant and viscosity enhancer, and or with low concentrations of a selective α-2 adrenergic receptor agonist.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS9089562B2Increasing visual depth of fieldLong durationOrganic active ingredientsSenses disorderAdrenergicMedicine
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably use aceclidine separate or together with a cycloplegic agent and / or with a nonionic surfactant and viscosity enhancer, and or with low concentrations of a selective α-2 adrenergic receptor agonist.
Owner:LENZ THERAPEUTICS INC
Compositions and Methods for the Improvement of Distance Vision and the Treatment of Refractive Errors of the Eye
ActiveUS20150290126A1Eliminating optical aberrationImprove visual acuityBiocideInorganic non-active ingredientsRefractive errorCryoprecipitate
The invention provides compositions and methods for the improvement of distance vision. The invention further provides compositions and methods for the treatment of refractive errors of the eye. The invention further provides compositions that preferably comprise aceclidine lyophilized with a cryoprecipitate separate or together with a diluent comprising a cycloplegic agent, a surfactant, and optionally a viscosity enhancer.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye
ActiveUS9314427B2Organic active ingredientsPharmaceutical delivery mechanismRefractive errorCryoprecipitate
The invention provides compositions and methods for the improvement of distance vision. The invention further provides compositions and methods for the treatment of refractive errors of the eye. The invention further provides compositions that preferably comprise aceclidine lyophilized with a cryoprecipitate separate or together with a diluent comprising a cycloplegic agent, a surfactant, and optionally a viscosity enhancer.
Owner:LENZ THERAPEUTICS INC
Storage stable compositions and methods for the treatment of refractive errors of the eye
ActiveUS9320709B2Organic active ingredientsPharmaceutical delivery mechanismRefractive errorOphthalmology
Owner:LENZ THERAPEUTICS INC
Contact lens compositions and methods for the treatment of presbyopia
The invention provides contact lens and contact lens storage compositions and methods for the treatment of presbyopia. The contact lens and contact lens storage compositions preferably comprise aceclidine and a cryoprotectant. The compositions optionally contain a cycloplegic agent.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS9844537B2Improve visionImprove eyesightHydroxy compound active ingredientsPharmaceutical delivery mechanismPolyolPreservative
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine and a polyol. The compositions optionally contain a cycloplegic agent, a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.
Owner:LENZ THERAPEUTICS INC
Compositions and Methods for the Treatment of Presbyopia
ActiveUS20160193194A1Eliminating optical aberrationImprove visual acuityBiocidePharmaceutical delivery mechanismPresbyopiaAceclidine
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine and a cycloplegic agent. The compositions optionally contain a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS10617763B2High viscosityReduce rednessOrganic active ingredientsSenses disorderPreservativeAceclidine
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine and a cryoprotectant. The compositions optionally contain a cycloplegic agent, a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS20200115377A1Improve acuityReduced comfortOrganic active ingredientsSenses disorderMedicineAceclidine
The invention provides compositions and methods for the treatment of presbyopia. The methods preferably comprise storing an aceclidine composition in a container having a headspace at a temperature from about 2 to about 8 degrees Celsius. The methods further comprise filling the container under an inert gas overlay and / or enclosing the container an anti-leaching material or disposing the container in a second container containing an anti-leaching material.
Owner:LENZ THERAPEUTICS INC
Compositions and Methods for the Treatment of Presbyopia
ActiveUS20160346259A1Eliminating optical aberrationImprove visual acuityOrganic active ingredientsPharmaceutical delivery mechanismPolyolPreservative
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine and a polyol. The compositions optionally contain a cycloplegic agent, a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS10959990B2Organic active ingredientsPharmaceutical delivery mechanismDisodium EdetateMannitol
The invention provides compositions and methods for the treatment of presbyopia. The compositions comprise aceclidine hydrochloride, polysorbate 80, mannitol, anhydrous hypromellose, disodium edetate dihydrate, benzalkonium chloride, sorbic acid and anhydrous sodium citrate and optionally tropicamide.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS10052313B2High viscosityReduce rednessOrganic active ingredientsPharmaceutical delivery mechanismPolyolPreservative
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine and a polyol. The compositions optionally contain a cycloplegic agent, a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.
Owner:LENZ THERAPEUTICS INC
Contact lens compositions and methods for the treatment of presbyopia
The invention provides contact lens and contact lens storage compositions and methods for the treatment of presbyopia. The contact lens and contact lens storage compositions preferably comprise aceclidine and a cryoprotectant. The compositions optionally contain a cycloplegic agent.
Owner:LENZ THERAPEUTICS INC
Methods for the treatment of myopia
The invention provides methods for the treatment of myopia. The compositions preferably comprise aceclidine. The compositions optionally contain a surfactant, a viscosity agent, a polyol and / or a selective α-2 adrenergic receptor agonist.
Owner:LENZ THERAPEUTICS INC
Contact lens compositions and methods for the treatment of presbyopia
InactiveUS20190240152A1Organic active ingredientsPharmaceutical delivery mechanismAceclidineCycloplegic agent
The invention provides contact lens and contact lens storage compositions and methods for the treatment of presbyopia. The contact lens and contact lens storage compositions preferably comprise aceclidine and a cryoprotectant. The compositions optionally contain a cycloplegic agent.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS20200281906A1Organic active ingredientsPharmaceutical delivery mechanismDisodium EdetateMannitol
The invention provides compositions and methods for the treatment of presbyopia. The compositions comprise aceclidine hydrochloride, polysorbate 80, mannitol, anhydrous hypromellose, disodium edetate dihydrate, benzalkonium chloride, sorbic acid and anhydrous sodium citrate and optionally tropicamide.
Owner:LENZ THERAPEUTICS INC
Compositions and Methods for the Treatment of Presbyopia
ActiveUS20160193193A1Eliminating optical aberrationImprove visual acuityBiocideHydroxy compound active ingredientsPresbyopiaViscosity
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine and a polyol. The compositions optionally contain a cycloplegic agent, a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
The invention provides compositions and methods for the treatment of presbyopia. The compositions comprise aceclidine hydrochloride, polysorbate 80, mannitol, anhydrous hypromellose, disodium edetate dihydrate and anhydrous sodium citrate and optionally brimonidine, benzalkonium chloride and / or sorbic acid.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS10836760B2Improve acuityReduced comfortOrganic active ingredientsSenses disorderMedicineAceclidine
The invention provides compositions and methods for the treatment of presbyopia. The methods preferably comprise storing an aceclidine composition in a container having a headspace at a temperature from about 2 to about 8 degrees Celsius. The methods further comprise filling the container under an inert gas overlay and / or enclosing the container an anti-leaching material or disposing the container in a second container containing an anti-leaching material.
Owner:LENZ THERAPEUTICS INC
Methods for the treatment of myopia
The invention provides methods for the treatment of myopia. The compositions preferably comprise aceclidine. The compositions optionally contain a surfactant, a viscosity agent, a polyol and / or a selective α-2 adrenergic receptor agonist.
Owner:LENZ THERAPEUTICS INC
Storage stable compositions and methods for the treatment of refractive errors of the eye
InactiveCN107920984AImprove acuityNo need for correctionOrganic active ingredientsSenses disorderRefractive errorOphthalmology
The invention provides compositions and methods for achieving storage stable aceclidine. The compositions preferably comprise aceclidine, a cycloplegic agent, a surfactant, a tonicity adjuster and optionally a viscosity enhancer and an antioxidant. The invention further provides methods for treating refractive errors of the eye with a storage stable aceclidine composition.
Owner:伦茨治疗股份有限公司
Compositions and Methods for the Treatment of Presbyopia
ActiveUS20180140708A1Eliminating optical aberrationImprove visual acuityOrganic active ingredientsSenses disorderPreservativeViscosity
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine and a cryoprotectant. The compositions optionally contain a cycloplegic agent, a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
ActiveUS11273150B2Improve acuityReduced comfortOrganic active ingredientsOrganic chemistryMedicineEngineering
The invention provides compositions and methods for the treatment of presbyopia. The methods preferably comprise storing an aceclidine composition in a container having a headspace at a temperature from about 2 to about 8 degrees Celsius. The methods further comprise filling the container under an inert gas overlay and / or enclosing the container an anti-leaching material or disposing the container in a second container containing an anti-leaching material.
Owner:LENZ THERAPEUTICS INC
Compositions and methods for the treatment of presbyopia
InactiveUS20180235946A1Eliminate side effectsCiliary induced headache areOrganic active ingredientsSenses disorderAceclidineViscosity
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine, an alpha-adrenergic agonist, a cryoprotectant and a non-ionic surfactant. The compositions optionally contain a viscosity enhancer.
Owner:PRESBYOPIA THERAPIES INC
Aceclidine isomers and scalemic mixtures thereof for the treatment of presbyopia
InactiveUS20200061036A1Organic active ingredientsSenses disorderActive agentAdrenergic receptor agonists
The invention provides compositions containing aceclidine isomers and scalemic mixtures thereof for the treatment of presbyopia. The compositions optionally contain an alpha-adrenergic agonist, a cycloplegic agent, a cryoprotectant, a non-ionic surfactant and / or a viscosity enhancer.
Owner:PRESBYOPIA THERAPIES INC
Compositions and methods for the treatment of presbyopia
InactiveCN108883102AReduce myopia blurImproved distance visionOrganic active ingredientsPharmaceutical non-active ingredientsPolyolPreservative
The invention provides compositions and methods for the treatment of presbyopia and other vision defects. The compositions preferably comprise aceclidine and a polyol and / or a cycloplegic agent. The compositions optionally contain a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.
Owner:PRESBYOPIA THERAPIES
Compositions and methods for the treatment of presbyopia
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine. The compositions optionally contain a surfactant and a viscosity agent.
Owner:LENZ THERAPEUTICS INC
Compositions for the improvement of distance vision and the treatment of refractive errors of the eye
The invention provides compositions and methods for the improvement of distance vision. The invention further provides compositions and methods for the treatment of refractive errors of the eye. The invention further provides compositions that preferably comprise aceclidine lyophilized with a cryoprecipitate separate or together with a diluent comprising a cycloplegic agent, a surfactant, and optionally a viscosity enhancer.
Owner:伦茨治疗股份有限公司
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com